Trade FBIO stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Fortress Biotech, Inc. (FBIO) is trading at US$2.49, down 1.58% today as of Sep 15, 16:00 EDT. The company has a market capitalisation of US$95.72M. Over the past 52 weeks, FBIO has traded between US$2.18 and US$4.53. On Syfe you can trade FBIO with $0 commission and add it to your watchlist.
| Previous close | US$2.53 |
|---|---|
| Market cap | US$95.72M |
| P/E ratio | 61.20 |
| 52-week range | US$2.18 – US$4.53 |
| Volume | 223.91K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Fortress Biotech, Inc.
Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL.
Year: 2011
Fortress Biotech Unit Closes $205 Million PRV Sale
Mar 30, 8:54 PM · MT Newswires
Fortress Biotech, Inc. (FBIO) stock is trading at US$2.49, -1.58% from the previous close of US$2.53.
The market cap for Fortress Biotech, Inc. (FBIO) stock is approximately US$95.72M.
The price-to-earnings ratio for Fortress Biotech, Inc. (FBIO) is 61.20, based on the latest reported earnings.
The 52-week high for Fortress Biotech, Inc. (FBIO) stock is US$4.53.
The 52-week low for Fortress Biotech, Inc. (FBIO) stock is US$2.18.
Fortress Biotech, Inc. (FBIO) does not currently pay a dividend.
Stay on top of FBIO
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
